Company intelligence / Profile preview

Emanate Biomedical

New York City, New York, United Stateslinkedin.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Emanate Biomedical has developed a patented, single-use, preloaded hydrogel-infused dental tray system for the treatment of oral diseases and wounds. A proof-of-concept clinical trial in patients with periodontitis demonstrated safety and efficacy as an adjunct to standard dental debridement. A larger randomized controlled clinical trial is planned for 2025 to further assess safety and effectiveness in post-scaling/root planing wound healing.

Therapeutic areas: OtherImmunology
Modalities: DeviceHydrogel-based drug delivery therapyBiologic (as hydrogel may deliver biologics)
Industry: Therapeutic Medical Devices

Partnerships

The McGuire Institute (clinical research partner/sponsor)

Beyond the preview

Go deeper on Emanate Biomedical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Emanate Biomedical.

Explore the full profile